Head Finance Business Partner New Product Launches (mfd)

 

Business Introduction

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.
Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.



Position Summary

The role of Head Finance Business Partner New Product Launches for Germany is an opportunity to join the Europe One Finance community and drive performance across our region.

Germany is GSK’s biggest market in Europe and a top three market globally, operating in an innovation driven environment. Strategic priorities include capitalizing on 15 upcoming launches, expanding real world evidence and clinical footprint, accelerating digital and AI enabled commercial excellence, and deepening partnerships with policymakers and healthcare stakeholders.

In this role, you will serve as finance head, owning decision grade Forecast Valuation and bottom up P&Ls that scale to EU, and partnering across Specialty, Oncology, and Vaccines to prepare L 24/L 18 launches, optimize resource allocation, and inform Medicines Commercialisation Team (MCT) decisions.

Your mission is to be a true finance partner, providing a strong voice in challenging and influencing decision-making. This involves interfacing with senior stakeholders, commercial teams and regional finance, providing strategic financial input, identifying opportunities and driving performance. You will lead Early‑Asset Forecast Valuation and Germany‑originated bottom‑up P&Ls (scalable to EU), align value‑to‑volume assumptions through Demand Review meeting/Launch Readiness review (DRM/LRR), and steer launch resourcing and investment prioritization to protect profitability while advancing GSK’s growth and innovation agenda.

Responsibilities
 

Early‑Asset Forecasting & P&L Ownership

• Forecast Valuation & P&L: Own decision‑grade Forecast Valuation and bottom‑up P&Ls for Early assets, including optimal resource/investment analysis, building base/upsides/downsides that are ready for governance and scalable to EU planning.

• Assumptions & Scenarios: Define, challenge epidemiology, uptake, price/access, and supply assumptions; maintain transparent and comprehensive scenario plans and R&O registers for governance milestones.

Launch Readiness & Resourcing

• L‑24/L‑18 Cadence: Contribute to L‑24/ L‑18 bottom‑up submissions, including resource implications and offline templates; support handshakes with Access, Medical, and Supply for LRR decision readiness.

• Activation Support: Translate forecast outcomes into clear investment asks and resourcing options, enabling timely activation decisions and first‑time‑right LRR outcomes.

Performance Integration & Reporting

• DRM: Integrate early‑asset assumptions into the DRM, reconcile value‑to‑volume, and track a 3‑10 years horizon with crisp variance narratives and mitigation plans.

• Standardize cross‑BU methodology (SBU, Oncology, Vx) so DE outputs can serve as EU scale‑up templates.

Pricing, Access & Market Economics

• Pricing Governance: Partner with Market Access to pressure‑test price corridors, run sensitivity analyses across access scenarios, and prepare evidence‑based recommendations for pricing approval forums.

nvestment Prioritization & Portfolio Scenarios

• ROI & Trade‑offs: Model investment options (medical, access, promo, field) and quantify returns to inform prioritization across assets and milestones.

• Scenario Planning: Lead structured what‑ifs on timing, label, access and capacity; articulate implications for EU scale‑up and Plan.

• Profitability Focus: Identify margin levers and SG&A guardrails for launch phases; embed actions into DRM/MPR follow‑up.

Data‑Driven Decision Making & Digital/AI

• AI‑enabled Forecasting: Leverage the AI forecasting roadmap where in‑scope; codify overlays for NPIs/tenders and continuously tune with Demand/Supply

• Advanced Analytics & Tools: Use Genie, MMM insights, and other enterprise data products to refine assumptions, spot opportunities, and accelerate analytics; promote adoption and good practice across Finance and Commercial

Qualifications/Skills

Basic Qualifications:

• Finance or business degree and/or Professional qualification (e.g. ACA, CIMA, ACCA, CPA, MBA or international equivalent).

• 5 years’ experience in financial roles

• Experience in financial modelling, scenario planning and investment appraisal for decision-making recommendations in complex business challenges. Demonstrated experience in financial planning/ forecasting, including understanding of financial systems and processes (CERPS, Bison, CF/CCC, VISTA)

• Ability to translate data into strategic recommendations and embed data-driven decision-making behaviours

Preferred Qualifications:

• Breadth of experience across different business areas, contributing to an enterprise level perspective 

• Demonstrated ability to influence and shape senior leadership decisions with material strategic and financial impact, building credibility and challenging constructively across global, regional, and LOC stakeholders

• Experience operating effectively with senior stakeholders in complex, cross functional, matrix environments

• Proven ability to lead and drive change in fast-moving, ambiguous environments with competing priorities

• Demonstrated risk management, process improvement, and project management skills

• Experience within the pharmaceutical industry or similarly highly regulated environments

• Experience leading digital transformation across finance or commercial teams, including automation, AI-enabled insights, and adoption of advanced analytics platforms (e.g., MMM, Genie). 

Work Location:

This role is based in Munich, Germany, and offers a hybrid working model, combining on-site and remote work.

Closing Date for Applications: 30th April 2026

Please take a copy of the Job Description, as this will not be available post closure of the advert. When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

#Li-Hybrid

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us at DE.Contact-Recruitment@gsk.com where you can also request a call.

Please note should your inquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a Recruitment FAQ guide. Click the link where you will find answers to multiple questions we receive.

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to ethnicity, colour, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/